NCT05546138 Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
| NCT ID | NCT05546138 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aalborg University Hospital |
| Condition | Neuropathy, Diabetic |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-10-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Predicting early onset neuropathy in people with type 1 diabetes
Eligibility Criteria
Inclusion Criteria: * Men and women aged 18-80 years * Diagnosed with diabetes (of any type) * No clinically established diabetic peripheral neuropathy at inclusion Exclusion Criteria: * Alcohol or drug abuse within the last year (prior to inclusion) * Chemotherapy (prior or within study period) or experimental medicine * Severe vitamin deficiencies * Inability to understand or comply with the examinations * Planned or likely discontinuation of care at Aalborg University Hospital * Known hematologic disorders resulting in a markedly reduced ability to stop small bleedings * Severe limb ischemia * Active diabetic foot ulcers * Previous amputations * Severe skin diseases or diseases known to cause neural damage * Pregnancy at inclusion
Contact & Investigator
Peter Vestergaard, PhD
STUDY CHAIR
Steno Diabetes Center North Denmark
Frequently Asked Questions
Who can join the NCT05546138 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Neuropathy, Diabetic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05546138 currently recruiting?
Yes, NCT05546138 is actively recruiting participants. Contact the research team at j.roeikjaer@rn.dk for enrollment information.
Where is the NCT05546138 trial being conducted?
This trial is being conducted at Aalborg, Denmark.
Who is sponsoring the NCT05546138 clinical trial?
NCT05546138 is sponsored by Aalborg University Hospital. The principal investigator is Peter Vestergaard, PhD at Steno Diabetes Center North Denmark. The trial plans to enroll 200 participants.